Global Neurovascular Access And Delivery Device Market 2022-2030

    Multi User License - $2,999

    In Stock

    Coming Soon

    GLOBAL NEUROVASCULAR ACCESS AND DELIVERY DEVICE MARKET

     

    INTRODUCTION

    Neurovascular access is used to treat a variety of illnesses and problems, including embolic stroke, brain aneurysms, arteriovenous malformations, and other issues.

    Infographics-Neurovascular Access And Delivery Device Market , Neurovascular Access And Delivery Device Market Size, Neurovascular Access And Delivery Device Market Trends, Neurovascular Access And Delivery Device Market Forecast, Neurovascular Access And Delivery Device Market Risks, Neurovascular Access And Delivery Device Market Report, Neurovascular Access And Delivery Device Market Share

     

    Any device used to distribute a product in the field is referred to as a delivery device (excluding syringes or other similar devices that are generally available for purchase). 

     

    GLOBAL NEUROVASCULAR ACCESS AND DELIVERY DEVICE MARKET  SIZE AND FORECAST

     

    The global neurovascular access and delivery device market accounted for $XX Billion in 2021 and is anticipated to reach $XX Billion by 2030, registering a CAGR of XX% from 2022 to 2030.

     

    RECENT ACQUISITIONS

    CERENOVUS, a new neurovascular company, was recently unveiled by Johnson & Johnson Medical Devices Companies during the Society of NeuroInterventional Surgery. The mission of CERENOVUS, whose name is a combination of the Latin words for “new” and “brain,” is to provide patients with hemorrhagic and ischemic strokes with cutting-edge therapies.

     

    The Johnson & Johnson Medical Devices Companies are dedicated to providing neurovascular care and have recently made targeted investments to increase the product portfolio for CERENOVUS.

     

    The recent acquisitions of Neuravi Limited, with its EmboTrap Revascularization Platform, and Pulsar Vascular Inc., with a focus on the endovascular treatment of wide-neck bifurcation aneurysms, significantly increase CERENOVUS’s capacity to meet unmet clinical requirements in these fields.

     

     Haselmeier, a manufacturer and developer of Swiss-German medication delivery devices, has been acquired by Sulzer.For the secure self-administration of liquid medications, Haselmeier is involved in the supply of solutions for subcutaneous injection systems.

     

    The business sells subcutaneous self-injection pens and other drug delivery systems using its own intellectual property for conditions like diabetes, osteoporosis, and growth abnormalities.

     

    Haselmeier offers solutions tailored to the needs of each client, from design and conception to product development, engineering, and industrialization in cutting-edge manufacturing facilities.

     

    RECENT PRODUCT DEVELOPMENT AND INNOVATION

    In order to lessen the difficulties encountered on a daily basis when working in this environment, the CorPath GRX Neurovascular System provides procedural precision, greater visualisation, and an optimum work environment during cerebral aneurysm treatments.

     

    The goal of Siemens Healthineers’ image-guided, robotic-assisted therapy is to improve patient outcomes while speeding the development of neurovascular technology today.

     

    The recently acquired radial artery access portfolio from Rist Neurovascular, Inc., which comprises the Rist 079 radial access guide catheter and Rist radial access selective catheter, has been expanded by Medtronic for its limited site release.

     

    The first catheter created exclusively for neurointerventions using the radial artery channel in the wrist is the Rist 079 Radial Access Guide Catheter. When compared to the femoral method, this is the first-of-its-kind device that optimises transition zones for the necessary navigability and support.

     

    RECENT PARTNERSHIP

    Today, industry and the medical community work together more and more to achieve medical breakthroughs. Physicians more frequently present an idea to the industry and, as a result of that collaboration, obtain funding for additional capabilities in research and development in order to provide a treatment solution that is more likely to become a standard treatment.

     

    The medical device industry’s workforce is here for the same reasons that medical professionals are; They want to assist others. We want to provide a treatment that has an impact. In order to assist the industry in providing therapies that are known to be effective, efficient, and effective, regulatory bodies frequently make requests for information and documentation on therapies.

     

    A crucial requirement is for a physician to receive training on interventions. Training is more than just learning about the nuances of a new device that has been approved for sale. You are obligated to provide instruction on everything from additional considerations of pre-, peri-, and post-procedure to device setup, initial access, and delivery education and training.

     

    Viz.ai and Cercare Medical Partner to Support Neurovascular Clinical Decision Making. Cercare Medical, which provides next-level medical imaging with CT and MRI, and Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, announced a partnership today. Cercare Perfusion, a patient-specific, fully automated perfusion software, will be incorporated into the Viz.ai platform as part of the partnership.

     

    In order to better serve healthcare facilities that use MR imaging in the patient workflow, Viz is expanding its imaging capabilities and features. The capabilities of the Viz.ai platform and the company’s flagship AI-powered neurovascular portfolio are enhanced by the incorporation of Cercare Perfusion technology.

     

    Cercare further enriches the workflow with layers of AI to produce volumetric measures, which directly impact clinical decision-making. Brain perfusion scans measure blood flow in the brain and are used to provide critically needed information on the extent of tissue damage caused, for example, by acute ischemic stroke.

     

    Quickly mapping brain perfusion deficits is crucial for minimizing tissue damage in acute stroke management.Viz.ai entered into this global partnership to increase access to the latest perfusion technology, which is designed to easily integrate into existing workflows to provide healthcare professionals with deep, fast, and reliable patient insights.

     

    Cercare uniquely provides maps illustrating oxygen availability, in addition to blood flow and volume. This allows more detailed assessment of tissue pathology and therefore optimized patient management for a variety of conditions, such as dementia and neoplasia.

     

    COMPANY PROFILE

     

    THIS REPORT WILL ANSWER FOLLOWING QUESTIONS

    1. What is the average cost per global neurovascular access and delivery device market right now and how will it change in the next 5-6 years?
    2. Average cost to set up a global neurovascular access and delivery device market in the US, Europe and China?
    3. How many global neurovascular access and delivery device markets are manufactured per annum globally? Who are the sub-component suppliers in different regions?
    4. What is happening in the overall public, globally?
    5. Cost breakup of a global neurovascular access and delivery device market and key vendor selection criteria
    6. Where is the global neurovascular access and delivery device market  manufactured? What is the average margin per equipment?
    7. Market share of global neurovascular access and delivery device market manufacturers and their upcoming products
    8. The most important planned global neurovascular access and delivery device market in next 2 years
    9. Details on network of major global neurovascular access and delivery device market and pricing plans
    10. Cost advantage for OEMs who manufacture global neurovascular access and delivery device market in-house
    11. 5 key predictions for next 5 years in global neurovascular access and delivery device market
    12. Average B-2-B global neurovascular access and delivery device market price in all segments
    13. Latest trends in global neurovascular access and delivery device market, by every market segment
    14. The market size (both volume and value) of the global neurovascular access and delivery device market in 2022-2030 and every year in between?
    15. Global production breakup of global neurovascular access and delivery device market, by suppliers and their OEM relationship

     

     

     

    Sl no Topic
    1 Market Segmentation
    2 Scope of the report
    3 Abbreviations
    4 Research Methodology
    5 Executive Summary
    6 Introduction
    7 Insights from Industry stakeholders
    8 Cost breakdown of Product by sub-components and average profit margin
    9 Disruptive innovation in the Industry
    10 Technology trends in the Industry
    11 Consumer trends in the industry
    12 Recent Production Milestones
    13 Component Manufacturing in US, EU and China
    14 COVID-19 impact on overall market
    15 COVID-19 impact on Production of components
    16 COVID-19 impact on Point of sale
    17 Market Segmentation, Dynamics and Forecast by Geography, 2022-2030
    18 Market Segmentation, Dynamics and Forecast by Product Type, 2022-2030
    19 Market Segmentation, Dynamics and Forecast by Application, 2022-2030
    20 Market Segmentation, Dynamics and Forecast by End use, 2022-2030
    21 Product installation rate by OEM, 2022
    22 Incline/Decline in Average B-2-B selling price in past 5 years
    23 Competition from substitute products
    24 Gross margin and average profitability of suppliers
    25 New product development in past 12 months
    26 M&A in past 12 months
    27 Growth strategy of leading players
    28 Market share of vendors, 2022
    29 Company Profiles
    30 Unmet needs and opportunity for new suppliers
    31 Conclusion
    32 Appendix

     

     

     

     

     

     

     

    0
      0
      Your Cart
      Your cart is emptyReturn to Shop